Rosiglitazone improves post-infarction left ventricular contractile function in rats

Chinese Medical Journal

Volumn 118, Issue 12, 2005, Pages 1028-1031

  Li, Bao ^a   Ma, Ye Xin ^a   Xie, Jun ^b   Yang, Bin ^b   Li, Zhi ^b   Wang, Hui Zhen ^b   Zhang, Dong ^b   Niu, Bo ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Myocardial infarction; PPAR

Indexed keywords

HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ROSIGLITAZONE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; FEEDING; FEMALE; GEL MOBILITY SHIFT ASSAY; HEART ATRIUM CONDUCTION; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; NONHUMAN; PROTEIN BINDING; RAT; SURVIVAL; THORACOTOMY; TREATMENT OUTCOME;

ANIMALS; ECHOCARDIOGRAPHY; FEMALE; HYDROXYL RADICAL; MYOCARDIAL CONTRACTION; NF-KAPPA B; PPAR GAMMA; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDES; THIAZOLIDINEDIONES; VENTRICULAR FUNCTION, LEFT;

EID: 21344464246     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Lehmann JM, Moore LB, Smith-Oliver TA, et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ). J Biol Chem 1995;270:12953-12956.
2. Shiomi T, Tsutsui H, Hayashidani S, et al. Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002;106:3126-3132.
3. Olivetti G, Capasso JM, Meggs LG, et al. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 1991;68:856-869.
4. Bethea JR, Castro M, Keane RW, et al. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 1998;18:3251-3260.
5. Bethea JR, Ohmori Y, Hamilton TA. A tandem GC box motif is necessary for lipopolysaccharide-induced transcription of the type II TNF receptor gene. J Immunol 1997;158:5815-5823.
6. Tian-li Y, Jun C, Weike B, et al. In vivo myocardial protection from ischemia/reperfusion by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation 2001;104:2588-2594.
7. Lygate CA, Hulbert K, Monfared M, et al. The PPAR-activated rosiglitazone does not alter remodeling but increse mortality in rats post-myocardial infarction. Cardiovasc Res 2003;58:632-637.
8. Monaco C, Paleolog E. Nuclear factor κB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res 2004;61:671-682.
9. Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997;96:2414-2420.
10. Xu KY, Zweier JL, Becker LC. Hydroxyl radical inhibits sarcoplasmic reticulum Ca (2 +)-ATPase function by direct attack on the ATP binding site. Circ Res 1997; 80:76-81.
11. Meldrum DR, Dinarello CA, Cloveland JC Jr., et al. Hydrogen peroxide induces tumor necrosis factor alphamediated cardiac injury by a p38 mitogen activated protein kinasedependent mechanisms. Surgery 1998; 124:291-296.